Switching from intravenous to subcutaneous infliximab in patients with hidradenitis suppurativa

被引：0
作者：
Luque, Mar [1 ]
Barboza, Lorenza [1 ]
Sandoval, Alejandra [1 ]
Fuertes, Irene [1 ]
机构：
[1] Hosp Clin Barcelona, Dept Dermatol, Barcelona, Spain
来源：
EXPERIMENTAL DERMATOLOGY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：145 / 145
页数：1
相关论文
共 4 条
  • [1] Switch to subcutaneous infliximab during the SARS-CoV-2 pandemic: preliminary results
    Arguelles-Arias, Federico
    Fernandez Alvarez, Paula
    Castro Laria, Luisa
    Maldonado Perez, Belen
    Belvis Jimenez, Maria
    Merino-Bohorquez, Vicente
    Caunedo Alvarez, Angel
    Calleja Hernandez, Miguel Angel
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2022, 114 (02) : 118 - 119
  • [2] High-dose, high-frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa
    Ghias, Mondana H.
    Johnston, Andrew D.
    Kutner, Allison J.
    Micheletti, Robert G.
    Hosgood, H. Dean
    Cohen, Steven R.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (05) : 1094 - 1101
  • [3] Subcutaneous Infliximab [CT-P13], a True Biologic 2.0. Real Clinical Practice Multicentre Study
    Huguet, Jose M.
    Garcia-Lorenzo, Victor
    Marti, Lidia
    Maria Paredes, Jose
    Joaquin Ramirez, Jose
    Pastor, Miguel
    Ruiz, Lucia
    Sanahuja, Ana
    Timoneda, Pilar
    Sanchis, Laura
    Alemany Perez, Gloria
    Maia Bosca-Watts, Marta
    [J]. BIOMEDICINES, 2022, 10 (09)
  • [4] Efficacy and Safety of Elective Switching from Intravenous to Subcutaneous Infliximab [CT-P13]: A Multicentre Cohort Study
    Smith, Philip J.
    Critchley, Lisa
    Storey, Daniel
    Gregg, Belle
    Stenson, June
    Kneebone, Andrew
    Rimmer, Tracy
    Burke, Stevena
    Hussain, Shamas
    Yi Teoh, Wan
    Vazeille, Stephan
    Serna, Solange
    Steel, Alan
    Derbyshire, Edmund
    Collins, Paul
    Dibb, Martyn
    Flanagan, Paul
    Probert, Christopher
    Verma, Ajay M.
    Subramanian, Sreedhar
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 (09) : 1436 - 1446
1